Loxo Oncology Inc (NASDAQ:LOXO)

183.59
Delayed Data
As of 3:54pm ET
 +4.97 / +2.79%
Today’s Change
69.00
Today|||52-Week Range
208.95
+118.09%
Year-to-Date
No recent news for Loxo Oncology Inc.

Today’s Trading

Previous close178.61
Today’s open178.67
Day’s range176.34 - 187.75
Volume652,859
Average volume (3 months)501,740
Market cap$4.1B
Data as of 3:54pm ET, 06/21/2018

Growth & Valuation

Earnings growth (last year)-53.47%
Earnings growth (this year)+118.12%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales110.80
Price/Book10.78

Competitors

 Today’s
change
Today’s
% change
RAREUltragenyx Pharmaceu...-3.10-3.63%
IRWDIronwood Pharmaceuti...+0.00+0.03%
FOLDAmicus Therapeutics ...-0.60-3.51%
SUPNSupernus Pharmaceuti...+0.23+0.39%
Data as of 3:55pm ET, 06/21/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)-$0.66
Annual revenue (last year)$21.3M
Annual profit (last year)-$148.9M
Net profit margin-698.95%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Josh Bilenker
VP-Business Operations &
Program Management
Sara Slifka
Corporate headquarters
Stamford, Connecticut

Forecasts